Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-19-027547

President and CEO sold 18,334 shares at an average $24.20 ($443,744)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2019-05-01 Sale −6,112 $24.09 $147,238 2,591,526 I: show line 1 in the form
Watts Ryan J. President and CEO 2019-05-02 Sale −6,111 $24.03 $146,847 2,585,415 I: show line 2 in the form
Watts Ryan J. President and CEO 2019-05-03 Sale −6,111 $24.49 $149,658 2,579,304 I: show line 3 in the form
Open-market sales · 18,334 sh · avg $24.20 · $443,744
Loading xslF345X03/doc4.xml…